MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: Characterization and antigen-specific activation

Cancer Research

Volumn 56, Issue 1, 1996, Pages 16-20

  Toso, John F ^a   Oei, Coreen ^a   Oshidari, Farshid ^c   Tartaglia, James ^b   Paoletti, Enzo ^b   Lyerly, H Kim ^a   Talib, Sohel ^c   Weinhold, Kent J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Virogenetics Inc   (United States)

^c Applied Immune Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; VIRUS VECTOR;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030051834     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Taylor, J , Weinberg, R., Tartaglia, J , Richardson, C., Alkatib, G., Briedis, D , Appel, M , Norton, E., and Paoletti, E. Non replicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins Virology, 187: 321-328, 1992.
2. Cadoz M., Strady, A., Meigier, B., Taylor, J , Tartaglia, J., Paoletti, E., and Plotkin, S. Immunisation with canarypox virus expressing rabies glycoprotein. Lancet, 339. 1429-1432, 1992.
3. Traversari, C , van der Bruggen, P., Luescher, I. F., Lurguin, C., Chomez, P., Van Pel, A., De Plaen E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized an HLA-A1 by CTL directed against tumor antigen MZ2-E. J. Exp. Med , 176: 1453-1457, 1992.
4. van der Bruggen, P , Szikora, J. P., Boel, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601*. Eur. J Immunol , 24: 2134-2140, 1994.
5. Brasseur, F., Marchand, M., Vanwijck, R., Herin, M., Lathe, B., Chomez, P., and Boon, T. Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors. Int. J. Cancer., 52, 839-841, 1992.
6. Perkus, M. E., Limbach, K., and Paoletti, E. Cloning and expression of foreign genes in vaccinia virus using a host range selection system J Virol., 63: 3829-3836, 1989
7. Tartaglia, J., Perkus, M. E , Taylor, J., Norton, E. K., Audonney, J. C., Cox, W. I., Davis, S. W., Van Der Hoeven, J., Meignier, B., Riviere, M., Languet, B., and Paoletti, E. NYVAC. A highly attenuated strain of vaccinia virus Virology, 188: 217-232, 1992.
8. Perkus, M. E., Kauffman, E B., Taylor, J , Mercer, S , Smith, D., Van Der Hoeven, J., and Paoletti, E. Methodology of using vaccinia virus to express foreign genes m tissue culture J. Tiss Cult. Methods, 15: 72-81, 1993.
9. β gene repertoire Proc. Natl Acad. Sci USA, 88: 2908-2912, 1991.
10. Ding, M , Beck, R. J., Keller, C J , and Fenton, R. G. Cloning and analysis of MAGE-1 related genes. Biochem Biophys. Res. Commun., 202: 549-555, 1994.
11. Yasumura, S , Hirabayashi, H , Schwartz, D. R., Toso, J. F., Johnson, S. T., Herberman, R. B., and Whiteside, T L. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res., 53. 1461-1468, 1993.
12. Topalian, S. L., Soloman, D., and Rosenberg, S. A. Tumor-specific cytolysis by lymphocytes infiltrating human melanoma. J. Immunol., 142: 3714-3725, 1989.
13. Darrow, T. L , Slingluff, C L., and Seigler, H F. The role of class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes: evidence for shared tumor antigens. J. Immunol. 142: 3329-3335, 1989.
14. Kawakami, Y., Zakut, R , Topalian, S. L., Stotter, H., and Rosenberg, S. A. Shared human melanoma antigens: recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol., 148. 638-643, 1992.
15. Disis, M. L , Calenoff, E., McLaughlin, G , Murphy, A. E., Chen, W., Groner, B , Jeshke, M , Lydon, N , McGlynn, E., Livingston, R. B., Moe, R., and Cheever, M A Existent T cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res., 54: 16-20, 1994
16. + T-cell immunity to mutated ras protein in pancreatic and colon cancer patients Cancer Res , 55: 2984-2987, 1995
17. + cytotoxic T-lymphocytes in the absence of exogenous help. J. Exp. Med., 177. 1791-1796, 1993.
18. Townsend, A., Rothbard, J., Gotch, F , Bahadur, G., Writh, D., and McMichael, A. The epitope of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell, 42: 959-968, 1986.
19. Celis, E., Fikes, J., Wentworth, P , Sidney, J., Southwood, S., Maewal, A., Del Guercio, M-F , Sette, A., and Livingston, B. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol. Immunol., 31. 1423-1430, 1994.
20. Gaudin, C., Dietrich, P. Robache, S , Guillard, M , Escudier, B., Lacombe, M. T., Kumar, A , Triebel, F., and Caignard, A. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma. Cancer Res., 55: 685-690, 1995.
21. McHeyzer-Williams, M G., and Davis, M. M Antigen-specific development of primary and memory T cells in vivo. Science (Washington DC), 268: 106-111, 1995
22. β usage during the primary immune response to HIV. Nature (Lond.), 370: 463-467, 1994.